The Addition of 400 cGY Total Body Irradiation to a Regimen Incorporating Once-Daily Intravenous Busulfan,Fludarabine, and Antithymocyte Globulin Reduces Relapse Without Affecting Nonrelapse Mortality in Acute Myelogenous Leukemia |
| |
| Affiliation: | 1. Department of Medicine and Oncology, Foothills Hospital and Tom Baker Cancer Centre, Calgary, Alberta, Canada;2. Department of Medicine and Oncology, CTI Clinical Trial and Consulting Services, Cincinnati, Ohio;3. Department of Medicine and Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
